Product Name :
Vimentin Antibody
EN
VIME; vimentin
Additional Information:
|Introduction Vimentin expression in human malignant glioma cells depends on cellular density, algorithms of drug delivery and chemo/radio treatment. Vimentin and detyrosinated microtubules provide structural support for the extensive microtentacles observed in detached tumor cells and a mechanism to promote successful metastatic spread. Primary colorectal carcinomas display aberrant expression of vimentin, and have activated Notch and TGFbeta signaling |Direct ELISA, Western Blot, Immuneprecipitation, immunohistochemistry. For intra-cellular staining, use 5-10 ul/106 cells. Wash twice with PBS/Azide before adding the appropr amount of secondary fluorescent reagent. Reactivity: Human. Immunogen: Purified Human Vimentin. Purification: Ion exchange column. Form of Antibody: 1ug/ml in PBS (after reconstitution). Clone: hVimentin. Isotype: mouse IgG1. Storage/Stability: Stable for 1 year at -20°C and 3 months at 4°C. For maximum recovery of the product, centrifuge the original v after thawing and before removing the cap. Aliquot to avoid repeated freezing and thawing.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Solanezumab Neuronal Signaling
CCR2 Rabbit mAb Protocol
RANKL/CD254 Antibody: RANKL/CD254 Antibody is an unconjugated, approximately 35 kDa, rabbit-derived, anti-RANKL/CD254 polyclonal antibody. RANKL/CD254 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, and predicted: rat, dog background without labeling.